Humanity’s List

MedicineEurope PMC

Ranked by formulaVerdict: Notable

Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade

Immune checkpoint blockade has transformed cancer therapy, but immune-related adverse events (irAEs) remain a major, sometimes fatal, limitation, and the lack of robust preclinical models has hindered mechanistic…

By Patra, Wolfgang, Ye +15Cell

Score█████░░░░░4.6

Caveats

  • Not randomized: its findings are associations.

VerdictWorth a reader's time today.

Read the original

Abstract

Immune checkpoint blockade has transformed cancer therapy, but immune-related adverse events (irAEs) remain a major, sometimes fatal, limitation, and the lack of robust preclinical models has hindered mechanistic insight. We present the lifestyle-induced susceptibility to irAEs (LISA) model, in which diet-driven metabolic and microbial alterations recreate human-like susceptibility to anti-PD-1 toxicity. LISA recapitulates multi-organ irAEs with immune infiltration and cytokine production, severity depending on sex, age, treatment modality, and immunotherapy response. Mechanistically, dysbiosis marked by Akkermansia muciniphila enrichment accompanies aberrant immune activation, driving regulatory T cell (Treg) fragility and CD8+ cytotoxic effector populations, both observed in patients with irColitis. Dietary reversal, metabolite supplementation, and blocking interferon (IFN)-γ production or signaling in Tregs restored Treg stability and resolved inflammation. Human-to-mouse fecal microbiome transfer interacts with recipient diet to shape susceptibility. Together, these findings identify dietary, microbial, and immune drivers of irAEs, which can be leveraged to improve immunotherapy responses while minimizing toxicity.

Dipyaman Patra, Katelyn Wolfgang, Chenxian Ye, Lora Rigatti, Kelsey Ertwine, Kristin M Morder, Jessica Jana, Ishita Baral, Drew Hurd, Kaitlin Bossong, Steven Mullett, Yingtong Dou, Stacy Gelhaus, Dario A A Vignali, Diwakar Davar, Anthony R Cillo, Greg M Delgoffe, Abigail E Overacre-Delgoffe

The editor's rubric

Heuristic review

Leverage3 / 5
A method or resource many groups across the field will adopt within a year.
10% of this desk’s rubric
Magnitude3 / 5
Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem.
20% of this desk’s rubric
Evidence3 / 5
Solid: multiple benchmarks or cohorts, ablations, fair baselines, released code or data.
32% of this desk’s rubric
Novelty3 / 5
A genuinely new approach to an open problem.
8% of this desk’s rubric
Trajectory2 / 5
Some room to improve with obvious engineering.
5% of this desk’s rubric
Stakes3 / 5
Meaningful benefit to many people within a few years.
25% of this desk’s rubric

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: method (we propose); stakes (mortality, major disease, prevention or cure). Red flags: not randomized.

How the score was computed

rank-2026-10-18

Score█████░░░░░4.6

Score = 10 × (80% × adjusted merit / 10 + 10% × attention + 10% × freshness)

Desks place stronger verdicts first, then use this score to order work within the same verdict.

Merit
5.9 / 10
Weighted rubric, evidence-gated.
Adjusted merit
4.7 / 10
Shrunk toward the desk prior by editor confidence (38%).
Attention
0%
Citations, upvotes, points, mentions.
Freshness
80%
Half-life decay since publication.
  • Citations0 (reference 20, via openalex, Oct 25, 2026, 05:48 UTC)

The record

  • Reviewed by heuristic-v10 on Oct 25, 2026, 06:17 UTC. Paper type: clinical.
  • Categories: Journal Article, Microbiome, Tregs, Akkermansia Muciniphila, Immune-related Adverse Events, Immune Checkpoint Blockade, Ifn-γ Signaling, Treg Fragility, Cd8(+) Trms
  • BRIEF, No.5 in the Biology edition of October 25, 2026.